Test for Patients' Treatment Response to Chron... - CLL Support

CLL Support

22,659 members38,889 posts

Test for Patients' Treatment Response to Chronic Lymphocytic Leukemia Cut to 1 Day

wmay13241 profile image
4 Replies

The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukemia has been developed at Cardiff University. The technology could guide doctors’ decisions on which drugs to give to patients. selectscience.net/industry-...

Written by
wmay13241 profile image
wmay13241
To view profiles and participate in discussions please or .
4 Replies
UKwoman profile image
UKwoman

Thanks for posting this. Sounds like really good news. Hope this testing soon becomes widely available for us.

Peggy4 profile image
Peggy4

Sounds good and could bring peace of mind to many. I wonder if it will be done for everyone automatically at diagnosis. Could potentially save a lot of anxiety.

Peggy

Cllcanada profile image
CllcanadaTop Poster CURE Hero

I hope they do some studies with STELA and novel therapies, since chemotherapy use in CLL is fading somewhat... but it might find selected patients who would get the best benefit from chemo, FISH markers and IGHV mutations markers aside...

Certainly is an advance

~chris 🇨🇦

Sushibruno profile image
Sushibruno

Great article!

You may also like...

Chronic lymphocytic leukemia

know if I ned to start treatment or wait till I have symptoms The treatment has no chemotherapy in...

Son diagnosed with Chronic Lymphocytic Leukemia

my 27 year old son was diagnosed with Chronic Lymphocytic Leukemia, His Doctor's told us he...

Information on chronic lymphocytic leukemia

Starting treatment next week with a infusion of obinutuzumab for 4 hours twice a week then off 28...

Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

non trial option for patients needing treatment after a targeted therapy...

Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

lus-rituximab-for-the-treatment-of-patients-with-chronic-lymphocytic-leukemia-cll--834973397.html...